"10.1371_journal.pone.0122613","plos one","2015-03-31T00:00:00Z","Manuel Romero-Gómez; Juan Turnes; Javier Ampuero; Itziar Oyagüez; Beatriz Cuenca; Juan Gonzalez-Garcia; Belén Muñoz-Molina; Rocio Aguilar; Sandra Leal; Ramon Planas; Javier Garcia-Samaniego; Moises Diago; Javier Crespo; Jose Luis Calleja; Miguel Angel Casado; Ricard Sola","UCM Digestive Diseases & ciberehd, Valme University Hospital, Sevilla, Spain; Complejo Hospitalario de Pontevedra, Pontevedra, Spain; Pharmacoeconomics & Outcomes Research Iberia, Madrid, Spain; Hospital Infanta Cristina, Parla, Madrid, Spain; Hospital Universitario La Paz, Madrid, Spain; Unidad de Hepatología, Roche Farma, Spain; FISEVI, Sevilla, Spain; Hospital Germans Trias i Pujol & ciberehd, Badalona, Barcelona, Spain; Hospital Carlos III & ciberehd, Madrid, Spain; Hospital General de Valencia, Valencia, Spain; Hospital Marqués de Valdecilla, Santander, Spain; Hospital Puerta de Hierro, Madrid, Spain; Hospital del Mar, IMIM, Barcelona, Spain","Wrote the paper: JA MR-G. Guarantor of the data: MR-G. Cost-analysis: IO MAC. Acquisition of data: MR-G JT JA BC JG-G BM-M RA SL RP JG-S MD JC JLC RS.","Co-authors Itziar Oyagüez and Miguel Ángel Casado are employed by Pharmacoeconomics & Outcomes Research Iberia. The study was funded by an unrestricted grant from Roche Farma (Spain). The Optim tool has been patented (P201330731). There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","03","Manuel Romero-Gómez","MRG",16,TRUE,NA,NA,NA,2,TRUE,FALSE,FALSE,0,NA,FALSE
